BeStock  
Stocks › Biotechnology › CORT

Corcept Therapeutics CORT

US equityMarket cap rank #1733Biotechnology
$63.62 −$1.36 (-2.09%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $63.62 0.00%
Open$64.07
Prev close$64.98
Day range$62.81 – $65.13
Volume1.09M
Market cap$6.96B
P/E (TTM)47.8
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings47.8x
CheapRich

Above its usual level · 69th percentile, 5-year average 58.7x

#2588 of 2996 stocks by PE (1 = cheapest)

Price / book8.4x
CheapRich

Above its usual level · 66th percentile, 5-year average 8.0x

#4914 of 5338 stocks by PB (1 = cheapest)

Price / sales7.2x
CheapRich

Around its usual level · 54th percentile, 5-year average 8.0x

#4360 of 5161 stocks by PS (1 = cheapest)

P/E over five years

-25x80x185x291xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$79.83
Price vs. fair value-20.3%Trading below the estimate
Star rating★★★★☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 8.35 – 8.04 66% (pricier than usual) #4914 of 5338 (1 = cheapest)
PE 47.83 11.45 58.68 69% (pricier than usual) #2588 of 2996 (1 = cheapest)
PS 7.23 4.21 7.97 54% (pricier than usual) #4360 of 5161 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on CORT.

Sign in to join the discussion.

Scroll to Top